Liver mass evaluation: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 8: Line 8:


==Liver Mass Evaluation==
==Liver Mass Evaluation==
*The algorithm below summarizes the initial liver mass evaluation  
*The algorithm below summarizes the initial liver mass evaluation
 


{{Familytree/start}}
{{Familytree | | | | | | | A01 | | | | | | A01= <div style="float: left; text-align:center; width: 15em; padding:1em;">'''Liver mass detected'''<br><SMALL> Adapted from Bonder et al.</SMALL></div>}}
{{Familytree | | | | | | | |!| | | | | | | }}
{{Familytree | | | | | | | A02 | | | | | | A02= <div style="float: left; text-align:center; width: 15em; padding:1em;">'''Relevant medical history to obtain:'''</div>}}
{{Familytree | | | | | | | A03 | | | | | | A03= <div style="float: left; text-align:left; width: 15em; padding:1em;"> ❑ Age and gender <br> ❑ Symptoms: jaundice, pain, nausea<br> ❑ Recent travel <br> ❑ Hepatitis serology<br> ❑ Iron studies<br> ❑ Use of oral contraceptives <br>❑ AFP levels <br>❑ From endemic area of hepatitis <br> ❑ History of chronic liver disease <br>❑ Physical findings</div>}}
{{Familytree | | | |,|-|-|-|^|-|-|-|.| | | }}
{{Familytree | | | B01 | | | | | | B02 | | | B01=<div style="float: left; text-align:center; width: 15em; padding:1em;">'''Chronic liver disease<br> Hepatitis B or C'''</div>
|B02=<div style="float: left; text-align:center; width: 15em; padding:1em;">  '''No history of chronic liver disease'''</div>}}
{{Familytree | | | |!| | | | | | | |!| | | | |}}
{{Familytree | | | |!| | | | | | | |!| | | | |}}
{{Familytree | | | |!| | | | | | | |!| | | | |}}
{{Familytree | | | |!| | | | | | | |!| | | | |}}
{{Familytree | | | C01 | | | | | | X02 | |C01=<div style="float: left; text-align:center; width: 15em; padding:1em;">'''Check AFP, triphasic CT or MRI''' <br> Follow-up screening guidelines as cirrhotic patient</div>|X02=<div style="float: left; text-align:center; width: 15em; padding:1em;"> '''Benign characteristics of a liver mass'''<br>Follow-up accordingly</div>}}}}
{{Familytree/end}}


==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 18:38, 25 March 2016

Liver Mass Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differential Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Evaluation of Liver Mass

Staging

History and Symptoms

Physical Examination

Laboratory Studies

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Liver mass evaluation On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Liver mass evaluation

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Liver mass evaluation

CDC on Liver mass evaluation

Liver mass evaluation in the news

Blogs on Liver mass evaluation

Directions to Hospitals Treating bone or soft tissue mass

Risk calculators and risk factors for Liver mass evaluation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

A hallmark feature in the evaluation of liver mass is the malignancy assessment. The evaluation approach of liver mass will mainly depend in the initial morphological evaluation of the mass (size, margins, contours, imaging pattern, and growth). Other characteristics, such as: location, clinical features, and distribution may be helpful for the therapeutical management, surveillance, and follow-up of liver mass. Lung mass can be divided into 2 categories: benign liver mass and malignant liver mass. Based upon these categories, complementary diagnostic studies and management, include: PET/CT scan, CT scan, non-surgical biopsy, and surgical resection.

Liver Mass Evaluation

  • The algorithm below summarizes the initial liver mass evaluation
}}
 
 
 
 
 
 
Liver mass detected
Adapted from Bonder et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Relevant medical history to obtain:
 
 
 
 
 
 
 
 
 
 
 
❑ Age and gender
❑ Symptoms: jaundice, pain, nausea
❑ Recent travel
❑ Hepatitis serology
❑ Iron studies
❑ Use of oral contraceptives
❑ AFP levels
❑ From endemic area of hepatitis
❑ History of chronic liver disease
❑ Physical findings
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chronic liver disease
Hepatitis B or C
 
 
 
 
 
No history of chronic liver disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check AFP, triphasic CT or MRI
Follow-up screening guidelines as cirrhotic patient
 
 
 
 
 
Benign characteristics of a liver mass
Follow-up accordingly
 

References